medigraphic.com
ISSN 1405-1710 (Print)

2017, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2017; 26 (1)

Oligosymptomatic Kawasaki disease

Velázquez GE, Cárdenas CA, Maya ASE, Orozco AAP

Language: Spanish
References: 26
Page: 10-14
PDF size: 258.88 Kb.


ABSTRACT

Kawasaki disease is a vasculitis mediated by immune complexes; it occurs in genetically predisposed individuals and is probably triggered by an infectious process.


REFERENCES

  1. Burns JC, Kushner HI, Bastian JF, Sjike H, Shimizu C, Matsubara T et al. Kawasaki disease: a brief history. Pediatrics. 2000; 106: E27.

  2. Kawasaki T. Pediatric acute mucocutaneous lymph node syndrome: clinical observation of 50 cases. Jpn J Allergy. 1967; 16: 178-222.

  3. Yamamoto T, Oya T, Watanabe A. Clinical features of Kawasaki disease. Jpn J Pediatr. 1968; 21: 291-297.

  4. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974; 54: 271-276.

  5. Landing BH, Larson EJ. Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics. 1976; 59: 651-662.

  6. Cook DH, Antia A, Attie F, Gersony WM, Kamiya T, Kato H et al. Results from an international survey of Kawasaki disease in 1979-82. Can J Cardiol. 1989; 5: 389-394.

  7. Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children. Acta Pediatr. 2003; 92: 694-697.

  8. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nature Genet. 2008; 40: 35-42.

  9. Onouchi Y, Onoue S, Tamari M, Wakui K, Fukushima Y, Yashiro M et al. CD40 ligand gene and Kawasaki disease. Europ J Hum Genet. 2004; 12: 1062-1068.

  10. Wang CL, Wu YT, Liu CA, Lin MW, Lee CJ, Huang LT et al. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics. 2003; 111: E140-147.

  11. Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T et al. Common variants in CASP3 confer susceptibility to Kawasaki disease. Human Mol Genet. 2010; 19: 2898-2906.

  12. Breunis WB, Davila S, Shimizu C, Oharaseki T, Takahashi K, van Houdt M et al. Disruption of vascular homeostasis in patients with Kawasaki disease. Arthritis Rheum. 2012; 64: 306-315.

  13. Laupland KB, Dele Davies H. Epidemiology, etiology and management of Kawasaki disease: State of the art. Pediatr Cardiol. 1999; 20: 177-183.

  14. Kawasaki T. Kawasaki disease. Acta Pediatr. 1995; 84: 713-715.

  15. Machado K, Gutiérrez S, Pirez C. Enfermedad de Kawasaki asociada a virus de Epstein-Barr. Arch Pediatr Urug. 2002; 73: 220-225.

  16. Prego PJ. Enfermedad de Kawasaki. Arch Pediatr Urug. 2003; 74: 99-113.

  17. Takahashi K, Oharaseki T, Yokouchi Y. Update on etio and immunopathogenesis of Kawasaki disease. Curr Opin Rheumatol. 2014; 26: 31-36.

  18. Uehara R, Igarashi H, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease patients with redness or crust formation at the Bacille Calmettee Guérin inoculation site. Pediatr Infect Dis J. 2010; 29: 430-433.

  19. Bayers S, Shulman ST, Paller AS. Kawasaki disease. Part I. Diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol. 2013; 69: 501.e1e11.

  20. Friter BS, Lucky AW. The perineal eruption of Kawasaki syndrome. Arch Dermatol. 1988; 124: 1805-1810.

  21. Knott PD, Orloff LA, Harris HP, Novak RE, Burns JC; Kawasaki Disease Multicenter Hearing Loss Study Group. Sensorineural hearing loss and Kawasaki disease: a prospective study. Am J Otolaryngol. 2001; 22: 343-348.

  22. Okura N, Okuda T, Shiotani S, Kohno M, Hayakawa H, Suzuki A et al. Sudden death as a late sequel of Kawasaki disease: postmortem CT demonstration of coronary artery aneurysm. Forensic Sci Int. 2013; 225: 85-88.

  23. Chen JJ, Ma XJ, Liu F, Yan WL, Huang MR, Huang M et al. Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012. Pediatr Infect Dis J. 2016; 35: 7-12. doi: 10.1097/INF.0000000000000914

  24. Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease: of a randomized trial. J Pediatr. 2003; 142: 611-616.

  25. Tremoulet AH, Jain S, Jaggi P, Jimenez FS, Pancheri JM, Sun X et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014; 383: 1731-1738.

  26. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 2004; 110: 2747-2771.




2020     |     www.medigraphic.com